Skip to main content
Log in

Somatomedin-binding proteins: What role do they play in the growth process?

  • Review
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The insulin-like growth factors (IGF-I and IGF-II) circulate bound to specific proteins. Two classes of binding proteins have been relatively well characterized differing in size, immunological activity, and physiological function. This review summarizes the more recent data on IGF-binding proteins, focusing on their possible clinical implications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

GH:

growth hormone

IGF-BP:

insulin-like growth factor binding protein

IGF (I and II):

insulin-like growth factor (I and II)

References

  1. Adam SO, Kapadia M, Millis B, Daughaday WH (1984) Release of insulin-like growth factors and binding protein activity into serum-free medium of cultured human fibroblasts. Endocrinology 115:520–526

    PubMed  Google Scholar 

  2. Atkinson PR, Weidman ER, Bhaumik B, Bala RM (1980) Release of somatomedin-like activity by cultured W1-38 human fibroblasts. Endocrinology 106:2006–2012

    PubMed  Google Scholar 

  3. Bar RS, Harrison LC, Baxter RC, Boes M, Dake BL, Booth B, Cox A (1987) Production of IGF-binding proteins by vascular endothelial cells. Biochem Biophys Res Commun 148:734–739

    PubMed  Google Scholar 

  4. Bar RS, Boes M, Sandra A (1988) IGF receptors in myocardial capillary endothelium: potential regulation of IGF-I transport to cardiac muscle. Biochem Biophys Res Commun 152:93–98

    PubMed  Google Scholar 

  5. Baumann G, Stolar MW, Amburn K, Barsano CP, De Vries BC (1986) A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab 62:134–141

    PubMed  Google Scholar 

  6. Baxter RC (1988) Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 67:265–272

    PubMed  Google Scholar 

  7. Baxter RC, Cowell CT (1987) Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab 65:432–440

    PubMed  Google Scholar 

  8. Baxter RC, Martin JL (1986) Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78:1504–1512

    PubMed  Google Scholar 

  9. Baxter RC, Martin JL, Wood MH (1987) Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. J Clin Endocrinol Metab 65:423–431

    PubMed  Google Scholar 

  10. Binoux M, Hossenlopp P (1988) Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 67:509–514

    PubMed  Google Scholar 

  11. Binoux M, Hossenlopp P, Lassarre C, Hardouin N (1981) Production of insulin-like growth factors and their carriers by rat pituitary gland and brain explants in culture. FEBS Lett 124:178–184

    PubMed  Google Scholar 

  12. Binoux M, Hossenlopp P, Hardouin S, Seurin D, Lassarre C, Gourmelen M (1986) Somatomedin (insulin-like growth factors)-binding proteins. Horm Res 24:141–151

    PubMed  Google Scholar 

  13. Blum WF, Ranke MB, Kietzmann K, Bierich JR (1988) Somatomedin binding protein (SmBP) in normals and in growth hormone deficiency (GHD). Pediatr Res 24:522–31A

    Google Scholar 

  14. Brinkman A, Groffen C, Kortleve DJ, Geurts van Kessel A, Drop SLS (1988) Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP-1). EMBO J 7:2417–2423

    PubMed  Google Scholar 

  15. Brismar K, Gutniak M, Povoa G, Werner S, Hall K (1988) Insulin regulates the 35 Kda IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 11:599–602

    PubMed  Google Scholar 

  16. Busby WH, Klapper DG, Clemmons DR (1988) Purification of a 31.000-Dalton insulin-like growth factor binding protein from human amniotic fluid. J Biol Chem 263:14203–14210

    PubMed  Google Scholar 

  17. Clemmons DR, Underwood LE (1986) Somatomedin-C/insulinlike growth factor I in acromegaly. Clin Endocrinol Metab 15: 629–653

    PubMed  Google Scholar 

  18. Clemmons DR, Van Wyk JJ (1984) Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab 13:113–143

    PubMed  Google Scholar 

  19. Clemmons DR, Underwood LE, Chatelain PG, Van Wyk JJ (1983) Liberation of immunoreactive somatomedin-C from its binding proteins by proteolitic enzymes and heparin. J Clin Endocrinol Metab 56:384–389

    PubMed  Google Scholar 

  20. Cotterill AM, Cowell CT, Baxter RC, McNeil D, Silink M (1988) Regulation of the growth hormone-independent insulin-like growth factor binding protein in children. J Clin Endocrinol Metab 67:882–887

    PubMed  Google Scholar 

  21. Daughaday WH, Phillips LS, Mueller MC (1976) The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 98:1214–1218

    PubMed  Google Scholar 

  22. De Larco J, Todaro GJ (1978) A human fibrosarcoma cell line producing multiplication stimulatory activity (MSA)-related peptides. Nature 272:356–358

    PubMed  Google Scholar 

  23. De Vroede MA, Tseng LYH, Katsoyannis PG, Nissley SP, Rechler MM (1986) Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media. J Clin Invest 77: 602–613

    PubMed  Google Scholar 

  24. Drop SLS, Valiquette G, Guyda HJ, Corvol MT, Posner BI (1979) Partial purification and characterization of a binding protein for insulin-like activity (ILAs) in human amniotic fluid: a possible inhibitor of insulin-like activity. Acta Endocrinol 90:505–518

    PubMed  Google Scholar 

  25. Elgin RG, Busby WH, Clemmons DR (1987) An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84:3254–3258

    PubMed  Google Scholar 

  26. Froesh ER, Burgi H, Muller WA, Humbel RE, Jakob A, Labhart A (1967) Non-suppressible insulin-like activity of human serum: purification, physiochemical and biochemical properties and its relation to total serum ILA. Rec Prog Horm Res 23:565–605

    PubMed  Google Scholar 

  27. Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ (1977) Estimation of somatomedin-C levels in normal and patients with pituitary disease by radioimmunoassay. J Clin Invest 60:648–657

    PubMed  Google Scholar 

  28. Hall K, Lundin G, Povoa G (1988) Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly, and anorexia nervosa. Acta Endocrinol 118:321–326

    PubMed  Google Scholar 

  29. Hardouin S, Hossenlopp P, Seurin D, Portolan G, Lassarre C, Binoux M (1987) Heterogeneity of insulin-like growth factor binding proteins and relationship between structure and affinity. Eur J Biochem 170:121–132

    PubMed  Google Scholar 

  30. Hintz RL, Liu F, Rosenfeld RG, Kemp SF (1981) Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J Clin Endocrinol Metab 53:100–104

    PubMed  Google Scholar 

  31. Holly JMP, Biddlecombe RA, Dunger DB, Edge JA, Auriel SA, Howell R, Chard T, Rees LH, Wass JAH (1988) Circadian variation of GH independent IGF-binding protein in diabetes mellitus and its relationship with insulin. A new role for insulin? Clin Endocrinol 29:667–675

    Google Scholar 

  32. Holly JMP, Smith CP, Dunger DB, Edge JA, Biddlecombe RA, Williams AJK, Howell R, Chard T, Savage MO, Rees LH, Wass JAH (1989) The levels of the small IGF-binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty. J Endocrinol 121:383–387

    PubMed  Google Scholar 

  33. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M (1986) Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138–143

    PubMed  Google Scholar 

  34. Julkunen M, Koistinen R, Aalto-Setala K, Seppala M, Janne DA, Kontula K (1988) Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Lett 236:295–302

    PubMed  Google Scholar 

  35. Koistinen R, Kalkkinen N, Huhtala ML, Seppala M, Bohn H, Rutanen EM (1986) Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. Endocrinology 118:1375–1378

    PubMed  Google Scholar 

  36. Leung DW, Spencer SA, Cachianes G, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI (1987) Growth hormone receptor and serum binding protein: purification cloning, and expression. Nature 330:537–543

    PubMed  Google Scholar 

  37. Martin JL, Baxter RC (1985) Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol. wt. growth hormone-dependent complex in human plasma. J Clin Endocrinol Metab 61:799–801

    PubMed  Google Scholar 

  38. Martin JL, Baxter RC (1988) Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs. Endocrinology 123:1907–1915

    PubMed  Google Scholar 

  39. Moses AC, Freinkel AJ, Knowles BB, Aden DP (1983) Demonstration that a human hepatoma cell line produces a specific insulin-like growth factor carrier protein. J Clin Endocrinol Metab 56: 1003–1008

    PubMed  Google Scholar 

  40. Ooi GT, Herington AC (1988) The biological and structural characterization of specific serum binding proteins for the insulin-like growth factors. J Endocrinol 118:7–18

    PubMed  Google Scholar 

  41. Orlowski CC, Chernausek SD (1988) Discordance of serum and tissue somatomedin levels in growth hormone-stimulated growth in rat. Endocrinology 123:44–49

    PubMed  Google Scholar 

  42. Povoa G, Roovete A, Hall K (1984) Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol 107:563–570

    PubMed  Google Scholar 

  43. Rinderknecht E, Humbel RE (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253:2769–2773

    PubMed  Google Scholar 

  44. Rinderknecht E, Humbel RE (1978) Primary structure of human insulin-like growth factor II. FEBS Lett 89:283–286

    PubMed  Google Scholar 

  45. Rutanen EM, Pekonen F, Makinen T (1988) Soluble 34 K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action. J Clin Endocrinol Metab 66:173–180

    PubMed  Google Scholar 

  46. Salmon WD, Daughaday WH (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825–836

    PubMed  Google Scholar 

  47. Schalch DS, Heinrich UE, Draznin B, Johnson CJ, Miller LL (1979) Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology 104:1143–1151

    PubMed  Google Scholar 

  48. Schwander JC, Hauri C, Zapf J, Froesh ER (1983) Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 113:297–305

    PubMed  Google Scholar 

  49. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266–272

    PubMed  Google Scholar 

  50. Suikkari AM, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H (1989) Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab 68:135–140

    PubMed  Google Scholar 

  51. Tanner JM (1962) Growth and adolescence, 2nd edn. Blackwell, Oxford

    Google Scholar 

  52. Underwood LE, D'Ercole AJ, Clemmons DR, Van Wyk JJ (1986) Paracrine functions of Somatomedins. Clin Endocrinol Metab 15:59–77

    PubMed  Google Scholar 

  53. Wilkins JR, D'Ercole AJ (1985) Affinity-labeled plasma somatomedin-C/insulin-like growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure. J Clin Invest 75:1350–1358

    PubMed  Google Scholar 

  54. Zapf J, Schoenle E, Jagars J, Sand I, Grunwald J, Froesch ER (1979) Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. J Clin Invest 63:1077–1084

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cianfarani, S., Holly, J.M.P. Somatomedin-binding proteins: What role do they play in the growth process?. Eur J Pediatr 149, 76–79 (1989). https://doi.org/10.1007/BF01995850

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01995850

Key words

Navigation